Malin Corporation (MLC.IR) Stock Price
Malin Corporation Price
Over the last 5 years Malin Corporation grew revenue by 12.4% annually, reaching 41.00 M EUR. Earnings per share have declined at 38.2% per year over the last 2 years. For Malin Corporation, the net margin of 213.9% is up versus -198.3% a few years ago. The consensus 12-month price target for Malin Corporation is 15.81 EUR, about 125.9% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 3% above its 52-week low.
Malin Corporation stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Malin Corporation over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Malin Corporation stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Malin Corporation's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Malin Corporation Price |
|---|---|
| 9/23/2026 | 7.00 EUR |
| 9/22/2026 | 7.00 EUR |
| 9/21/2026 | 6.80 EUR |
| 9/18/2026 | 6.80 EUR |
| 9/16/2026 | 7.00 EUR |
| 9/15/2026 | 7.00 EUR |
| 9/14/2026 | 7.00 EUR |
| 9/11/2026 | 7.00 EUR |
| 9/10/2026 | 7.00 EUR |
| 9/9/2026 | 7.00 EUR |
| 9/8/2026 | 7.00 EUR |
| 9/4/2026 | 7.00 EUR |
| 9/3/2026 | 7.00 EUR |
| 9/2/2026 | 7.00 EUR |
| 9/1/2026 | 7.00 EUR |
| 8/31/2026 | 7.00 EUR |
| 8/28/2026 | 7.00 EUR |
| 8/27/2026 | 7.00 EUR |
| 8/26/2026 | 7.00 EUR |
| 8/25/2026 | 7.00 EUR |
| 8/21/2026 | 7.00 EUR |
| 8/20/2026 | 7.00 EUR |
| 8/19/2026 | 7.00 EUR |
| 8/18/2026 | 7.00 EUR |
| 8/17/2026 | 7.00 EUR |
| 8/14/2026 | 7.00 EUR |
| 8/13/2026 | 7.00 EUR |
| 8/12/2026 | 6.95 EUR |
| 8/11/2026 | 7.00 EUR |
| 8/10/2026 | 7.00 EUR |
Malin Corporation Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Malin Corporation Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.00 | 42.00 | 41.00 | 38.00 | 34.00 | 41.00 | – | – | – | – | – | – |
| – | 90.91 | -2.38 | -7.32 | -10.53 | 20.59 | – | – | – | – | – | – |
| 13.64 | 26.19 | 26.83 | 10.53 | 20.59 | 24.39 | – | – | – | – | – | – |
| 3.00 | 11.00 | 11.00 | 4.00 | 7.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| -27.00 | -81.00 | -45.00 | -44.00 | -3.00 | 94.00 | -2.00 | – | -3.00 | -2.00 | -3.00 | -3.00 |
| -122.73 | -192.86 | -109.76 | -115.79 | -8.82 | 229.27 | – | – | – | – | – | – |
| -44.00 | -83.00 | -98.00 | -46.00 | -5.00 | 87.00 | 37.00 | 12.00 | – | – | – | -4.00 |
| – | 88.64 | 18.07 | -53.06 | -89.13 | -1,840.00 | -57.47 | -67.57 | – | – | – | – |
| 39.40 | 41.80 | 45.70 | 45.90 | 49.03 | 49.23 | 44.74 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Malin Corporation generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Malin Corporation retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Malin Corporation's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Malin Corporation has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Malin Corporation's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Malin Corporation stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Malin Corporation Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Malin Corporation business model & stock analysis
Malin Corporation SWOT Analysis
Strengths
Malin Corporation is a well-established company in its industry, with a strong track record of success and a solid customer base.
The company has a diverse range of high-quality products and services, offering a competitive advantage in the market.
Malin Corporation has a skilled and experienced workforce, enabling efficient operations and excellent customer service.
Weaknesses
One of the weaknesses of Malin Corporation is its heavy reliance on a few key customers, which poses a significant risk to the business if those relationships are disrupted.
The company may also face challenges in keeping up with rapidly evolving technology and industry trends.
Malin Corporation has relatively high operational costs, which can put pressure on profitability.
Opportunities
There are several potential opportunities for Malin Corporation to explore, such as expanding into new markets or introducing innovative products/services.
The company can also benefit from strategic partnerships or acquisitions to enhance its capabilities and market presence.
The growing demand for sustainable and environmentally-friendly solutions presents a chance for Malin Corporation to align its products with these trends.
Threats
Malin Corporation faces potential threats from intense competition in the market, which may impact its market share and pricing power.
Economic downturns or fluctuations can also pose risks to the company's profitability and financial stability.
Regulatory changes in the industry can impact Malin Corporation's operations and require adjustments to comply with new standards.
Malin Corporation Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Malin Corporation historical P/E ratio, EBIT multiple, and P/S ratio
Malin Corporation annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Malin Corporation's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Malin Corporation's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Malin Corporation's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Malin Corporation shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Malin Corporation forecasts and price targets in September 2026
Analyst Price Targets 2026Malin Corporation shareholder structure
| % | Name |
|---|---|
3.20398% | |
1.27080% | |
1.26872% | |
1.21004% | |
1.18146% | |
0.02548% |
Malin Corporation Beneficial Ownership Filings (SEC 13D/G)
Malin Corporation Executives and Management Board
12 members · avg. age 61 · 17 % women
Management
Mr. Neil McLoughlin
General Counsel, Company Secretary
David Dobrosky
Senior Analyst
Mr. Peter Schwartzman
Member of Senior Management Team
Board of Directors
Mr. Liam Daniel (63)
Non-Executive Chairman of the Board · since 2019
Ms. Fiona Dunlevy
Executive Director
Mr. Luke Corning (43)
Non-Executive Director
Dr. Jean-Michel Cossery
Non-Executive Director
Dr. Kirsten Drejer (69)
Non-Executive Director
Mr. Owen Hughes (50)
Non-Executive Director
Frequently asked questions about Malin Corporation
The business model of Malin Corporation PLC is focused on strategic investments in life sciences companies with significant growth potential. Malin aims to provide capital, expertise, and operational support to enable these companies to reach their full potential and generate substantial returns. By investing in a diverse portfolio of innovative life sciences businesses, Malin seeks to create value for its shareholders and contribute to the advancement of breakthrough technologies and therapies. With an emphasis on long-term partnerships, Malin aims to drive sustainable growth in the life sciences sector by identifying and supporting promising companies in areas such as biotechnology, pharmaceuticals, and medical devices.
Malin Corporation PLC is primarily active in the industries of healthcare and life sciences.
The main competitors of Malin Corporation PLC in the market are [competitor names]. These competitors pose a challenge to Malin Corporation PLC by offering similar products and services [specific to the industry], thereby competing for market share. However, Malin Corporation PLC has positioned itself uniquely in the market by [highlighting key differentiators or strengths], giving it a competitive edge. Despite the competition, Malin Corporation PLC continues to strive for excellence through its innovative offerings and strategic initiatives in order to maintain and expand its market presence.
Malin Corporation PLC is an Irish-based global life sciences investment company. Founded in 2015, its primary focus is on creating long-term shareholder value through strategic investments in innovative companies. Malin seeks to partner with businesses across various life sciences sectors, including biotechnology, therapeutics, medical devices, and diagnostics. With a goal to support the development of breakthrough technologies, Malin engages in active collaboration and provides financial and strategic support to its investee companies. While continually expanding its portfolio, Malin maintains a strong commitment to driving advances in healthcare and delivering value to its shareholders.
Malin Corporation PLC has achieved several significant milestones. Firstly, the company successfully completed its initial public offering (IPO) on the Irish Stock Exchange in 2015, raising substantial funds for its investment portfolio. In 2016, Malin Corporation acquired a strategic stake in Poseida Therapeutics, an innovative gene engineering company. The company further expanded its portfolio by investing in promising life science companies like Immunocore, Kymab, and Serenus Biotherapeutics. In 2019, Malin Corporation celebrated the FDA approval of its investee company, Outpost Medicine's drug, for the treatment of overactive bladder. These achievements demonstrate Malin Corporation PLC's commitment to investing in breakthrough medical technologies and its potential for long-term growth.
Malin Corporation PLC primarily operates in Ireland.
Malin Corporation PLC represents a strong set of values and a well-defined corporate philosophy. The company is dedicated to delivering long-term shareholder value through strategic investments in innovative life sciences companies. Malin Corporation aims to support diverse and forward-thinking businesses that have the potential to positively impact global health. By fostering growth and nurturing breakthrough technologies, Malin Corporation PLC promotes collaboration and excellence within the life sciences industry. With a steadfast commitment to ethical practices and responsible investments, Malin Corporation PLC strives to enhance patient outcomes and contribute to the advancement of healthcare worldwide.
Analysts currently set an average price target of 15.81 EUR for the Malin Corporation stock (median: 15.81 EUR), implying +125.9 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Malin Corporation stock: 4 recommend buying, 1 holding and 0 selling.
Malin Corporation PLC is an innovative Irish company specializing in investing in medical products. The company operates in various business areas, including the development and manufacture of pharmaceutical products, investment in innovative biotechnology startups, and the establishment of partnerships for scientific research projects. The manufacture of medical products is Malin's main business area. The company offers a wide range of products, ranging from drugs for rare diseases to antibiotics. The products are manufactured to the highest quality standards and are available to patients worldwide. An important part of Malin's business model is investing in innovative biotechnology startups. The company strives to find and support new technologies that contribute to improving human health. By collaborating with other companies and investors in the biotechnology field, Malin can advance innovative research and development that is of great benefit to its customers. Malin has also established partnerships for scientific research projects. Together with internationally leading research institutions and universities, the company is committed to the development of new drugs and therapies to meet the needs of patients. This collaboration aims to achieve scientific breakthroughs and find new treatment options for serious diseases. Overall, Malin's business model is focused on developing and providing innovative and effective drugs and therapies for patients. The company places special emphasis on adhering to high standards in research and production. By collaborating with other companies and research institutions, Malin achieves a broader base of knowledge, technology, and skills to remain competitive in the market. In summary, Malin Corporation PLC is an innovative company with a wide portfolio of medical products, investments in biotechnology startups, and research collaborations. With its focus on quality and innovation, Malin is a growing company that contributes to improving human health with its business model.
The revenue cannot currently be calculated for Malin Corporation.
The expected profit of Malin Corporation is -4.19 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Malin Corporation is currently -31.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Malin Corporation stock.
The P/S cannot be calculated for Malin Corporation currently.
The Eulerpool Quality Score for Malin Corporation is 1/10.
The ISIN of Malin Corporation is IE00BVGC3741. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Malin Corporation is MLC.IR. The ticker symbol is used to trade Malin Corporation shares on the stock exchange.
Malin Corporation paid dividends every year for the past 0 years.
Malin Corporation is assigned to the 'Health' sector.
The dividends of Malin Corporation are distributed in EUR.
Malin Corporation stock
Malin Corporation Peer Group
Malin Corporation FIGI
All fundamentals and in-depth analysis of Malin Corporation
Our stock analysis for Malin Corporation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Malin Corporation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.